News
Eli Lilly Settles Mounjaro Trademark Suit With Clinics
The voluntary dismissal was filed in federal court on June 16, 2026, nearly two weeks after a judge rejected an earlier proposed resolution. The suit accused the clinics of using Eli Lilly's trademarks to promote compounded versions of the weight-loss drugs.
This settlement is part of Eli Lilly's broader enforcement campaign against entities selling unapproved compounded tirzepatide products while referencing the company's branded marks.
The dismissal concludes the specific action against the Seattle-area clinics without further reported terms.
Sources: https://www.law360.com/health/articles/2490404/eli-lilly-settles-mounjaro-tm-suit-against-seattle-area-clinics https://www.vitallaw.com/news/trademark-w-d-wash-medical-clinics-accused-of-infringing-mounjaro-and-zepbound-marks-fail-to-state-counterclaims-eli-lilly/ipm016a4f17a3745a4699839d85dcdda2ce1a
Sources
- https://www.law360.com/health/articles/2490404/eli-lilly-settles-mounjaro-tm-suit-against-seattle-area-clinics
- https://www.vitallaw.com/news/trademark-w-d-wash-medical-clinics-accused-of-infringing-mounjaro-and-zepbound-marks-fail-to-state-counterclaims-eli-lilly/ipm016a4f17a3745a4699839d85dcdda2ce1a